Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
260M
-
Number of holders
-
719
-
Total 13F shares, excl. options
-
195M
-
Shares change
-
-374K
-
Total reported value, excl. options
-
$4.58B
-
Value change
-
-$22M
-
Put/Call ratio
-
1.12
-
Number of buys
-
296
-
Number of sells
-
-367
-
Price
-
$23.52
Significant Holders of Organon & Co. - Common Stock (OGN) as of Q1 2023
852 filings reported holding OGN - Organon & Co. - Common Stock as of Q1 2023.
Organon & Co. - Common Stock (OGN) has 719 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 195M shares
of 260M outstanding shares and own 74.96% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (31.7M shares), BlackRock Inc. (16.2M shares), Mawer Investment Management Ltd. (13.3M shares), STATE STREET CORP (12.8M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (8.36M shares), Invesco Ltd. (7.01M shares), LORD, ABBETT & CO. LLC (6.62M shares), JANUS HENDERSON GROUP PLC (6.32M shares), Bank of New York Mellon Corp (5.45M shares), and GEODE CAPITAL MANAGEMENT, LLC (5.44M shares).
This table shows the top 719 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.